{
  "id": 10969976,
  "title": "DA Davidson raises Paysign stock price target to $15 on growth outlook",
  "url": "https://urgent.news/2026/09/30/da-davidson-raises-paysign-stock-price-target-to-15-on-growth-outlook",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T15:10:45.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/da-davidson-raises-paysign-stock-price-target-to-15-on-growth-outlook-93CH-4925508"
  },
  "original_language": "en",
  "account": "On Tuesday, investment firm DA Davidson increased its price target for Paysign Inc. (NASDAQ:PAYS) to $15.00, up from $12.00, while retaining a Buy rating for the shares. Currently, Paysign's stock is trading at $13.05, marking a remarkable 150% gain year-to-date, despite InvestingPro data suggesting potential overvaluation relative to its intrinsic value.\n\nThe price target elevation stems from DA Davidson's enhanced confidence in the company's growth prospects within the Patient Affordability niche, following multiple interactions with management over the past two months. The firm's revised outlook aligns with multiple analysts revising earnings upwards and projecting a year-over-year increase in net income.\n\nIn line with these positive assessments, DA Davidson has also revised its 2027 and introduced 2028 forecasts for Paysign. The upgraded price target and expanded forecasts underscore the firm's positive assessment of the company's growth potential.\n\nFurthermore, Paysign Inc. recently reported strong second-quarter 2026 earnings, exceeding Wall Street estimates. The company reported earnings of $0.11 per share on revenue of $28.25 million, surpassing analyst expectations of $0.06 per share and $26.35 million in revenue. This performance marks the second consecutive quarter in which Paysign has surpassed expectations, showcasing consistent outperformance relative to market forecasts.\n\nThese developments reflect a promising trajectory for Paysign, with management highlighting the company's consistent ability to exceed analyst projections. The recent earnings report and positive outlook revisions position Paysign as a stock with substantial growth potential, as highlighted by its upgraded price target and expanded forecasts by DA Davidson.",
  "summary": null,
  "key_points": [
    "DA Davidson raises Paysign stock price target to $15.00 from $12.00",
    "Company's shares currently trade at $13.05, up 150% year-to-date",
    "DA Davidson cites growth prospects in Patient Affordability niche"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}